Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Leukemia & Lymphoma|August 1, 1996
The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimenM Bertini, R Freilone, U Vitolo, et al.
Haematologica|January 1, 1994
Probability of cure in elderly Hodgkin's disease patientsA Levis, L Depaoli, A Urgesi, et al.
Genes, Chromosomes & Cancer|May 1, 1996
Molecular heterogeneity of B-lineage diffuse large cell lymphomaG Volpe, U Vitolo, A Carbone, et al.
International Journal of Clinical & Laboratory Research|August 5, 1998
The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapyF Dammacco, F Silvestris, G L Castoldi, et al.
Haematologica|September 1, 1996
Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patientsA Levis, L Depaoli, M Bertini, et al.
British Journal of Haematology|June 1, 1997
Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocolF Giona, L Annino, R Rondelli, et al.
Blood|January 29, 2000
Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano LinfomiM Federico, U Vitolo, P L Zinzani, et al.
Haematologica|May 1, 1997
Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin)M Bertini, R Freilone, B Botto, et al.
British Journal of Haematology|September 30, 1998
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoS Keating, T de Witte, S Suciu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphomaU Vitolo, S Cortellazzo, A M Liberati, et al.
Pageof 8